{"id":"NCT01084005","sponsor":"Boehringer Ingelheim","briefTitle":"Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes","officialTitle":"A Phase III Randomised, Double Blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of Linagliptin (5 mg) Administered Orally Once Daily Over 24 Weeks in Type 2 Diabetic Patients (Age >= 70 Years) With Insufficient Glycaemic Control( HbA1c >= 7.0) Despite Metformin and/or Sulphonylurea and/or Insulin Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-03","primaryCompletion":"2011-06","completion":null,"firstPosted":"2010-03-10","resultsPosted":"2012-07-18","lastUpdate":"2014-01-29"},"enrollment":241,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"linagliptin","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"linagliptin","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of the current study is to investigate the efficacy, safety and tolerability of linagliptin (5 mg / once daily) compared to placebo given for 24 weeks as add-on therapy to stable treatment in elderly patients with T2DM with insufficient glycaemic control","primaryOutcome":{"measure":"HbA1c Change From Baseline to Week 24","timeFrame":"Baseline and week 24","effectByArm":[{"arm":"Placebo","deltaMin":0.04,"sd":0.07},{"arm":"Linagliptin 5 mg","deltaMin":-0.61,"sd":0.06}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"70 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":34,"countries":["Australia","Canada","Denmark","Netherlands","Sweden"]},"refs":{"pmids":["25236917","24169807","23948125"],"seeAlso":["http://trials.boehringer-ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/results/1218/1218.63_Literature.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":79},"commonTop":["Hypoglycaemia","Nasopharyngitis","Hyperglycaemia","Urinary tract infection","Diarrhoea"]}}